Difference between revisions of "Diosgenin"
From Coastal Wiki
(→Notes) |
Dronkers J (talk | contribs) |
||
| (14 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | {{Definition|title= | + | {{Tocright}} |
| + | {{Definition|title=diosgenin | ||
| − | |definition=Diosgenin is a pharmaceutical used for the synthesis of cortisone, progesterone, and other steroid products | + | |definition=Diosgenin is a pharmaceutical used for the synthesis of cortisone, progesterone, and other steroid products<ref name="wiki">[http://en.wikipedia.org/wiki/Diosgenin www.wikipedia.org August 12 2009]</ref>.}} |
== Notes == | == Notes == | ||
| + | |||
| + | |||
{| class="toccolours" border="1" style="float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: right; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! bgcolor="#FF8888" | Diosgenin | ! bgcolor="#FF8888" | Diosgenin | ||
|- | |- | ||
| − | | align="center" bgcolor="#FFFFFF" | [[Image:Diosgenin.png| | + | | align="center" bgcolor="#FFFFFF" | [[Image:Diosgenin.png|200px|Diosgenin]] |
|- | |- | ||
! bgcolor="#8888FF" | Formula | ! bgcolor="#8888FF" | Formula | ||
| Line 15: | Line 18: | ||
|} | |} | ||
| − | Diosgenin is made by hydrolysis of saponins, which are extracted from ''Dioscorea villosa'', a plant which grows in North America. It is also present in a number of other plant species which mainly occur in North America | + | Diosgenin is made by hydrolysis of saponins, which are extracted from ''Dioscorea villosa'', a plant which grows in North America. It is also present in a number of other plant [[species]] which mainly occur in North America<ref name="wiki">[http://en.wikipedia.org/wiki/Diosgenin http://en.wikipedia.org/wiki/Diosgenin]</ref>. |
| − | <ref name="wiki">[http://en.wikipedia.org/wiki/Diosgenin http://en.wikipedia.org/wiki/Diosgenin]</ref>. Extracts of''Dioscorea villosa'' containing diosgenin are sold in a variety of pharmacy and health food stores because of their presumed ability to minimize post-menopausal symptoms | + | Extracts of ''Dioscorea villosa'' containing diosgenin are sold in a variety of pharmacy and health food stores because of their presumed ability to minimize post-menopausal symptoms<ref>[http://www.raysahelian.com/diosgenin.html www.raysahelian.com August 12 2009]</ref>. It is also thought to induce apoptosis in cancer cells, and to reduce high blood pressure<ref>[http://www.find-health-articles.com/rec_pub_18071250-antioxidative-hypolipidemic-effects-diosgenin-steroidal-saponin-yam.htm Son IS, Kim JH, Sohn HY, Son KH, Kim JS, Kwon CS. 2007 Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci Biotechnol Biochem. 2007 Dec;71(12):3063-71. Epub 2007 Dec 7.]</ref><ref name="an">[http://cebp.aacrjournals.org/cgi/content/full/13/8/1392 Jayadev Raju, Jagan M.R. Patlolla, Malisetty V. Swamy and Chinthalapally V. Rao 2004 Diosgenin, a Steroid Saponin of Trigonella foenum graecum (Fenugreek), Inhibits Azoxymethane-Induced Aberrant Crypt Foci Formation in F344 Rats and Induces Apoptosis in HT-29 Human Colon Cancer Cells Cancer Epidemiology Biomarkers & Prevention Vol. 13, 1392-1398, August 2004]</ref>. |
| − | It has a very low water solubility 0.02 mg/l, is very hydrophobic is therefore in the marine environment | + | It has a very low water solubility 0.02 mg/l, is very hydrophobic and is therefore expected in the marine environment to be mostly associated to organic matter, particles and sediments. It is also expected to have a high potential towards [[bioaccumulation]]. <ref>[http://old.iupac.org/publications/pac/2003/pdf/7511x1933.pdf Pim de Voogt and Bert van Hattum 2003 Critical factors in exposure modelling of endocrine active substances Pure Appl. Chem., Vol. 75, Nos. 11–12, pp. 1933–1948, 2003]</ref> |
<P> | <P> | ||
<BR> | <BR> | ||
| Line 32: | Line 35: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| + | {{author | ||
| + | |AuthorID=19826 | ||
| + | |AuthorFullName=Daphnis De Pooter | ||
| + | |AuthorName=Daphnisd}} | ||
| − | [[Category: | + | [[Category:Toxicity chemicals]] |
Latest revision as of 13:09, 9 August 2020
Definition of diosgenin:
Diosgenin is a pharmaceutical used for the synthesis of cortisone, progesterone, and other steroid products[1].
This is the common definition for diosgenin, other definitions can be discussed in the article
|
Notes
| Diosgenin |
|---|
|
| Formula |
| C27H42O3 |
Diosgenin is made by hydrolysis of saponins, which are extracted from Dioscorea villosa, a plant which grows in North America. It is also present in a number of other plant species which mainly occur in North America[1]. Extracts of Dioscorea villosa containing diosgenin are sold in a variety of pharmacy and health food stores because of their presumed ability to minimize post-menopausal symptoms[2]. It is also thought to induce apoptosis in cancer cells, and to reduce high blood pressure[3][4].
It has a very low water solubility 0.02 mg/l, is very hydrophobic and is therefore expected in the marine environment to be mostly associated to organic matter, particles and sediments. It is also expected to have a high potential towards bioaccumulation. [5]
Environmental standards and legislation
Included in the OSPAR list of substances of priority action
References
- ↑ 1.0 1.1 www.wikipedia.org August 12 2009 Cite error: Invalid
<ref>tag; name "wiki" defined multiple times with different content - ↑ www.raysahelian.com August 12 2009
- ↑ Son IS, Kim JH, Sohn HY, Son KH, Kim JS, Kwon CS. 2007 Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci Biotechnol Biochem. 2007 Dec;71(12):3063-71. Epub 2007 Dec 7.
- ↑ Jayadev Raju, Jagan M.R. Patlolla, Malisetty V. Swamy and Chinthalapally V. Rao 2004 Diosgenin, a Steroid Saponin of Trigonella foenum graecum (Fenugreek), Inhibits Azoxymethane-Induced Aberrant Crypt Foci Formation in F344 Rats and Induces Apoptosis in HT-29 Human Colon Cancer Cells Cancer Epidemiology Biomarkers & Prevention Vol. 13, 1392-1398, August 2004
- ↑ Pim de Voogt and Bert van Hattum 2003 Critical factors in exposure modelling of endocrine active substances Pure Appl. Chem., Vol. 75, Nos. 11–12, pp. 1933–1948, 2003
Please note that others may also have edited the contents of this article.
|
